Correlation Between Virax Biolabs and LMF Acquisition
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and LMF Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and LMF Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and LMF Acquisition Opportunities, you can compare the effects of market volatilities on Virax Biolabs and LMF Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of LMF Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and LMF Acquisition.
Diversification Opportunities for Virax Biolabs and LMF Acquisition
0.56 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Virax and LMF is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and LMF Acquisition Opportunities in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LMF Acquisition Oppo and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with LMF Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LMF Acquisition Oppo has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and LMF Acquisition go up and down completely randomly.
Pair Corralation between Virax Biolabs and LMF Acquisition
Given the investment horizon of 90 days Virax Biolabs Group is expected to generate 1.93 times more return on investment than LMF Acquisition. However, Virax Biolabs is 1.93 times more volatile than LMF Acquisition Opportunities. It trades about 0.09 of its potential returns per unit of risk. LMF Acquisition Opportunities is currently generating about -0.05 per unit of risk. If you would invest 104.00 in Virax Biolabs Group on August 31, 2024 and sell it today you would earn a total of 93.00 from holding Virax Biolabs Group or generate 89.42% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virax Biolabs Group vs. LMF Acquisition Opportunities
Performance |
| Timeline |
| Virax Biolabs Group |
| LMF Acquisition Oppo |
Virax Biolabs and LMF Acquisition Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virax Biolabs and LMF Acquisition
The main advantage of trading using opposite Virax Biolabs and LMF Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, LMF Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LMF Acquisition will offset losses from the drop in LMF Acquisition's long position.| Virax Biolabs vs. Revelation Biosciences | Virax Biolabs vs. Kiora Pharmaceuticals | Virax Biolabs vs. Quoin Pharmaceuticals Ltd | Virax Biolabs vs. Neurobo Pharmaceuticals |
| LMF Acquisition vs. ZyVersa Therapeutics | LMF Acquisition vs. Sonnet Biotherapeutics Holdings | LMF Acquisition vs. Revelation Biosciences | LMF Acquisition vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |